Acinetobacter baumannii is a Gram-negative bacillus that causes multiple infections that can become severe.Carbapenems were once considered one of the drugs of choice for the treatment of Acinetobacter baumannii infection.However,with the emergence of carbapenem-resistant Acinetobacter baumannii,there are fewer and fewer sensitive drugs available in the clinic,and how to treat the infection of carbapenem-resistant Acinetobacter baumannii has become an urgent problem to be solved.This article summarized the latest research results in the treatment of carbapenem-resistant Acinetobacter baumannii from three aspects:Current treatment status,new compounds and new treatment methods,aiming to provide references for the clinical treatment and development of new drugs for carbapenem-resistant Acinetobacter baumannii.
维普
万方数据